Post by Kimberly Ha

Founder & CEO at KKH Advisors

Universal Brain just announced an FDA 510(k) clearance for its Neurotique™ platform, which offers a five-minute assessment to measure cognitive and emotional brain function in support of psychiatric diagnosis and treatment. Founded by Kazu Okuda, MD and featuring Chief Scientist Greg Hajack (ex-Google X), the company will launch its clinical offering this summer to 250 clinics. Read the article in Forbes by Naveen Rao: https://lnkd.in/gFVTGTqB

Post content